These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 34399777)

  • 1. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms.
    Qi Y; Mo K; Zhang T
    Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
    Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X
    Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCAPH regulates gastric cancer progression through DNA damage response.
    Wang Y; Li JQ; Yang ZL; Wang L; Zhang JC; Sun YF; Li ZY; Qin L
    Neoplasma; 2022 Mar; 69(2):283-291. PubMed ID: 34962823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells.
    Liao L; Cheng H; Liu S
    Oncol Lett; 2022 Sep; 24(3):317. PubMed ID: 35949592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer.
    Zheng YZ; Liang L
    Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
    Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
    Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking down Sterol regulatory element binding protein 2 (SREBF2) inhibits the Serine Protease 8 (PRSS8) /sodium channel epithelial 1alpha subunit (SCNN1A) axis to reduce the cell proliferation, migration and epithelial-mesenchymal transformation of ovarian cancer.
    Cai C; Zhang Y; Peng X
    Bioengineered; 2021 Dec; 12(2):9390-9400. PubMed ID: 34823420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
    Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
    Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OCT4 induces EMT and promotes ovarian cancer progression by regulating the PI3K/AKT/mTOR pathway.
    Xie W; Yu J; Yin Y; Zhang X; Zheng X; Wang X
    Front Oncol; 2022; 12():876257. PubMed ID: 36033461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DMBT1 suppresses cell proliferation, migration and invasion in ovarian cancer and enhances sensitivity to cisplatin through galectin-3/PI3k/Akt pathway.
    Ma N; Zhao Y
    Cell Biochem Funct; 2020 Aug; 38(6):801-809. PubMed ID: 32424818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAPH serves as a prognostic factor and promotes the tumor progression in glioma through PI3K/AKT signaling pathway.
    Liang J; Yun D; Jin W; Fan J; Wang X; Wang X; Li Y; Yu S; Zhang C; Li T; Yang X
    Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38587786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
    Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
    Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1.
    Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM
    Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
    Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
    Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.